BG100693A - Thrombopoietin - Google Patents

Thrombopoietin

Info

Publication number
BG100693A
BG100693A BG100693A BG10069396A BG100693A BG 100693 A BG100693 A BG 100693A BG 100693 A BG100693 A BG 100693A BG 10069396 A BG10069396 A BG 10069396A BG 100693 A BG100693 A BG 100693A
Authority
BG
Bulgaria
Prior art keywords
thrombopoietin
tpo
isolated
tpoare
thereplication
Prior art date
Application number
BG100693A
Other languages
Bulgarian (bg)
Other versions
BG63639B1 (en
Inventor
Dan Eaton
SAUVAGE Frederic DE
Original Assignee
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/196,689 external-priority patent/US8357513B1/en
Priority claimed from US08/249,376 external-priority patent/US8192955B1/en
Priority claimed from US08/348,657 external-priority patent/US6660256B1/en
Application filed by Genentech, Inc. filed Critical Genentech, Inc.
Publication of BG100693A publication Critical patent/BG100693A/en
Publication of BG63639B1 publication Critical patent/BG63639B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Vehicle Body Suspensions (AREA)
  • Information Transfer Systems (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Isolated thrombopoietin (TPO), isolated DNA encoding TPO, andrecombinant or synthetic methods of preparing and purifying TPOare disclosed. Various forms of ZPO are shown to influence thereplication, differentiation or maturation of blood cells,especially megakaryocytes and megakaryocyte progenitor cells.Acconiingly, these compounds may be used for treatment ofthrombocytopenia.
BG100693A 1994-01-03 1996-07-02 THROMBOPOIETIN-MpI-LIGAND POLYPEPTIDE BG63639B1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US17655394A 1994-01-03 1994-01-03
US18560794A 1994-01-21 1994-01-21
US08/196,689 US8357513B1 (en) 1994-01-03 1994-02-15 Nucleic acids encoding mpl ligand (thrombopoietin) and fragments thereof
US22326394A 1994-04-04 1994-04-04
US08/249,376 US8192955B1 (en) 1994-01-03 1994-05-25 Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof
US34865894A 1994-12-02 1994-12-02
US08/348,657 US6660256B1 (en) 1994-01-03 1994-12-02 Porcine mpl ligand
PCT/US1994/014553 WO1995018858A1 (en) 1994-01-03 1994-12-28 Thrombopoietin

Publications (2)

Publication Number Publication Date
BG100693A true BG100693A (en) 1998-01-30
BG63639B1 BG63639B1 (en) 2002-07-31

Family

ID=27569151

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100693A BG63639B1 (en) 1994-01-03 1996-07-02 THROMBOPOIETIN-MpI-LIGAND POLYPEPTIDE

Country Status (28)

Country Link
EP (1) EP0738323A1 (en)
JP (2) JPH09508262A (en)
CN (1) CN1134539C (en)
AU (1) AU704266B2 (en)
BG (1) BG63639B1 (en)
CA (1) CA2178482C (en)
CZ (1) CZ296130B6 (en)
DK (1) DK149194A (en)
ES (1) ES2114786B1 (en)
FI (1) FI121573B (en)
FR (1) FR2714670B1 (en)
GB (1) GB2285446B (en)
HR (1) HRP941020A2 (en)
HU (1) HUT75657A (en)
IE (1) IE72517B1 (en)
IL (1) IL112184A (en)
IT (1) IT1283770B1 (en)
LU (1) LU88573A1 (en)
LV (1) LV11632B (en)
NL (1) NL9500010A (en)
NO (1) NO326903B1 (en)
NZ (1) NZ278726A (en)
PT (1) PT101627B (en)
RO (1) RO117110B1 (en)
SG (1) SG47030A1 (en)
SI (1) SI9420079A (en)
SK (1) SK282265B6 (en)
WO (1) WO1995018858A1 (en)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968502A (en) 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
HU218893B (en) * 1994-03-31 2000-12-28 Amgen Inc. Water soluble compositions and methods for stimulating megakaryocyte growth and differentiation
US5986049A (en) * 1994-12-30 1999-11-16 Zymogenetics, Inc. Purified thrombopoietin and method of making it
TW387940B (en) * 1995-01-17 2000-04-21 Kirin Brewery Anti-tpo monodonal antibody
AU4658596A (en) 1995-02-03 1996-08-21 G.D. Searle & Co. Novel c-mpl ligands
CN1161468C (en) * 1995-02-15 2004-08-11 安姆根有限公司 MPL ligand analogs
US5989538A (en) * 1995-02-15 1999-11-23 Amgen Inc. Mpl ligand analogs
US5696250A (en) * 1995-02-15 1997-12-09 Amgen Inc. DNA encoding megakaryocyte growth and development factor analogs
TW434021B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable TPO-containing compositions
TW434020B (en) * 1995-03-15 2001-05-16 Kirin Brewery Methods for preventing adsorption of thrombopoietin (TPO), and stable top-containing compositions
ZA964382B (en) * 1995-06-06 1997-12-01 Genentech Inc Lymphotoxin and thrombopoietin for use in the treatment of cancer.
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
BR9608587A (en) 1995-06-07 1999-01-05 Glaxo Group Ltd Compound that binds to the thrombopoietin receptor pharmaceutical composition and process for treating a patient suffering from a disorder
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
TW497972B (en) * 1995-06-08 2002-08-11 Kirin Brewery Stable thrombopoietin (TPO)-containing lyophilized compositions
US6066318A (en) * 1995-10-05 2000-05-23 G.D. Searle & Co. Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
US6031071A (en) * 1996-01-24 2000-02-29 Biophage, Inc. Methods of generating novel peptides
US5879673A (en) * 1996-01-25 1999-03-09 Genentech, Inc. Administration of thrombopoietin on a single day only
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
NZ334103A (en) * 1996-08-13 2000-09-29 Zymogenetics Inc an expression vector used to transform or transfect a host cell to make a thrombopoietin polypeptide, the cultured yeast cell thereof and the thrombopoietin polypeptide
CA2288964A1 (en) * 1997-05-21 1998-11-26 Genentech, Inc. Novel administration of thrombopoietin
US5980893A (en) * 1997-07-17 1999-11-09 Beth Israel Deaconess Medical Center, Inc. Agonist murine monoclonal antibody as a stimulant for megakaryocytopoiesis
US6342220B1 (en) 1997-08-25 2002-01-29 Genentech, Inc. Agonist antibodies
US20030228666A1 (en) 1998-06-30 2003-12-11 Daewoong Pharmaceutical Co., Ltd. Novel human thrombopoietin mutein
KR20000006549A (en) * 1998-06-30 2000-01-25 윤재승 A novel human thrombopoietin mutein
AU773891C (en) 1998-10-23 2005-02-17 Kirin-Amgen Inc. Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
CY2010012I2 (en) * 2000-05-25 2020-05-29 Novartis Ag THROMBOPOIETIN MIMETICS
UY26317A1 (en) * 2000-08-30 2000-10-31 Alfonso Cayota Carlos Pritsch PRODUCTION SYSTEM OF HUMAN THROMBOPOYETINE BY CELLS OF MAMMALS IN CULTIVATION
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides
US7332474B2 (en) 2001-10-11 2008-02-19 Amgen Inc. Peptides and related compounds having thrombopoietic activity
EP1452093A4 (en) 2001-11-15 2007-08-15 Kirin Brewery Chimeric nonhuman animal
KR100467750B1 (en) * 2001-11-29 2005-01-24 씨제이 주식회사 Fusion protein having the enhanced in vivo activity of erythropoietin
US20030191056A1 (en) 2002-04-04 2003-10-09 Kenneth Walker Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
NZ566812A (en) 2002-09-18 2009-07-31 Ortho Mcneil Pharm Inc Methods of increasing platelet and hematopoietic stem cell production
US7576056B2 (en) 2003-08-28 2009-08-18 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
NZ551447A (en) * 2004-05-18 2010-08-27 Intrexon Corp Methods for dynamic vector assembly of DNA cloning vector plasmids
EP1773400A2 (en) 2004-07-08 2007-04-18 Amgen Inc. Therapeutic peptides
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US9012605B2 (en) 2006-01-23 2015-04-21 Amgen Inc. Crystalline polypeptides
WO2007098547A1 (en) * 2006-03-01 2007-09-07 Apollo Life Sciences Limited A molecule and chimeric molecules thereof
US7981425B2 (en) 2006-06-19 2011-07-19 Amgen Inc. Thrombopoietic compounds
AU2007278748B2 (en) 2006-07-24 2013-08-15 The University Of Queensland Method of producing a population of cells
CA2687141C (en) 2007-05-22 2014-04-01 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
WO2010085086A2 (en) 2009-01-20 2010-07-29 한올바이오파마 주식회사 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
WO2014089478A1 (en) * 2012-12-07 2014-06-12 University Of Tennessee Research Foundation Methods of numerical analysis for platelet disorders and computer-readable media and systems for performing the same
CA3177929A1 (en) * 2012-12-21 2014-06-26 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
CN103555760B (en) * 2013-10-18 2015-05-20 江苏康禾生物制药有限公司 Preparation method and preparation of recombinant human thrombopoietin
TR201807610T1 (en) * 2015-12-21 2018-06-21 Brainon Inc COMPOSITION FOR IMPROVING MEMORY, LEARNING SKILL AND COGNITIVE SKILLS
GB201700621D0 (en) 2017-01-13 2017-03-01 Guest Ryan Dominic Method,device and kit for the aseptic isolation,enrichment and stabilsation of cells from mammalian solid tissue
US20230212565A1 (en) * 2019-09-20 2023-07-06 Ractigen Therapeutics Nucleic acid molecule for treating thrombocytopenia and application thereof
KR20220119439A (en) 2019-12-20 2022-08-29 인스틸 바이오 유케이 리미티드 Apparatus and method for isolating tumor-infiltrating lymphocytes and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260417A (en) 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
CA2123430C (en) * 1991-12-06 2004-02-10 Cornelia M. Gorman Prohormone convertase transformed cells
IL139335A (en) 1994-01-03 2005-08-31 Genentech Inc Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia

Also Published As

Publication number Publication date
SK282265B6 (en) 2001-12-03
NO326903B1 (en) 2009-03-16
DK149194A (en) 1995-07-04
SG47030A1 (en) 1998-03-20
SK87596A3 (en) 1997-11-05
FI962723A (en) 1996-09-03
CZ192296A3 (en) 1997-05-14
JPH10113186A (en) 1998-05-06
IE72517B1 (en) 1997-04-23
HUT75657A (en) 1997-05-28
AU1514695A (en) 1995-08-01
IL112184A (en) 2004-07-25
AU704266B2 (en) 1999-04-15
CZ296130B6 (en) 2006-01-11
NO962783L (en) 1996-09-03
NO962783D0 (en) 1996-07-02
LV11632A (en) 1996-12-20
ES2114786A1 (en) 1998-06-01
FR2714670B1 (en) 1997-01-10
IT1283770B1 (en) 1998-04-30
FI962723A0 (en) 1996-07-02
CN1141061A (en) 1997-01-22
LV11632B (en) 1997-04-20
GB2285446A (en) 1995-07-12
SI9420079A (en) 1997-02-28
JPH09508262A (en) 1997-08-26
CA2178482A1 (en) 1995-07-13
IE950002A1 (en) 1995-07-12
HRP941020A2 (en) 1997-04-30
GB2285446B (en) 1999-07-28
CN1134539C (en) 2004-01-14
FI121573B (en) 2011-01-14
HU9601805D0 (en) 1996-08-28
NZ278726A (en) 1998-06-26
IL112184A0 (en) 1995-03-15
PT101627B (en) 1996-11-29
WO1995018858A1 (en) 1995-07-13
PT101627A (en) 1995-11-30
ES2114786B1 (en) 1999-01-01
RO117110B1 (en) 2001-10-30
LU88573A1 (en) 1995-06-01
GB9425831D0 (en) 1995-02-22
FR2714670A1 (en) 1995-07-07
CA2178482C (en) 2012-01-03
BG63639B1 (en) 2002-07-31
ITTO950002A0 (en) 1995-01-02
ITTO950002A1 (en) 1995-07-03
NL9500010A (en) 1995-08-01
EP0738323A1 (en) 1996-10-23

Similar Documents

Publication Publication Date Title
BG100693A (en) Thrombopoietin
GR3031166T3 (en) Pyrazolo and pyrrolopyridines
ZA939271B (en) Pyrrolopyrimidines
WO1999010494A3 (en) Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
EP0294272A3 (en) Needleless injector, especially for dental use
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
PL340836A1 (en) Novel compounds
DE3171620D1 (en) A dried, sterilized, gamma-globulin-fixed column and a process for preparing the same
CA2000786A1 (en) 3-piperidinyl-1,2-benzisoxazoles
GB9221163D0 (en) Dna compounds
IL106894A0 (en) Dorsal tissue affecting factor and compositions
ATE285177T1 (en) THIOLE FOR PROMOTING THE GROWTH OF HOMETOPOIETIC PROGENICIAL CELLS
IL84092A0 (en) Glycopeptidic antibiotics
LTIP1753A (en) Dna sequences coding for proteins, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
EP0054330A3 (en) Dna sequences encoding the various allelic forms of mature thaumatin, and cloning vehicles comprising said dna's and their use in transforming microorganisms
IL132534A0 (en) 20(S) camptothecin glycoconjugates
ES8500225A1 (en) 3-Phenoxy-1-azetidinecarboxamides and their use and preparation.
MX9604762A (en) Novel sulfonamides and process for the preparation thereof.
AU7383087A (en) Fused imidazoheterocyclic compounds
DE69011465D1 (en) Use of human ADF (= Adult T-cell leukemia-derived factor) for the manufacture of drugs.
MY134493A (en) Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method
AU2459188A (en) Anticoagulative protein pp4-x, and its preparation and use
HK1019770A1 (en) Il-6 mutein
ECSP951356A (en) THROMBOPOYETINE
MX9803272A (en) Lubeluzole n-oxide.